OSX share price boosted (up 10%) on announcement
Osteopore secures lead role in Clinical-industrial Partnership with National Dental Centre Singapore and A*STAR research institutes through A$19m project, develops next generation jaw implant to access the A$1.26b dental bone graft and membrane market
The project encompasses the development of a combination product with patented biological additives and polymer compound to enhance the bone regeneration capability and clinical outcomes. Expected outcomes include shorter surgical procedures and faster recovery time for patients.
• Findings from the project will be used to form the basis of Osteopore’s next generation products. The dental bone graft and membrane market has an estimated value of A$1.26b according to Verified Market Research, with 10% of the global dental jaw surgeries conducted in APAC.
• The total contribution by all parties including Singapore’s Foundation centre is A$18.7m, with Osteopore contributing A$1.8m in cash over three years. Osteopore is the industry lead in this project, bringing together three major Singaporean national research institutions, each with the expertise crucial to the execution.
• The translational study builds on intellectual property approvals for Osteopore’s magnesium-composite materials, previously obtained by the Osteopore team in several regions, including Singapore, Europe, and China.